Anna Alisi Selected Research

Biological Products

7/2020	Harnessing Omics Approaches on Advanced Preclinical Models to Discovery Novel Therapeutic Targets for the Treatment of Metastatic Colorectal Cancer.
7/2012	Expression of multidrug resistance-associated proteins in paediatric soft tissue sarcomas before and after chemotherapy.
5/2009	The pediatric NAFLD fibrosis index: a predictor of liver fibrosis in children with non-alcoholic fatty liver disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anna Alisi Research Topics

Disease

105	Non-alcoholic Fatty Liver Disease 05/2022 - 10/2007
37	Fibrosis (Cirrhosis) 01/2022 - 06/2008
21	Insulin Resistance 03/2022 - 06/2008
17	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 02/2008
17	Inflammation (Inflammations) 09/2021 - 10/2010
16	Fatty Liver 01/2022 - 02/2010
12	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022 - 05/2009
11	Liver Diseases (Liver Disease) 10/2020 - 09/2009
10	Neoplasms (Cancer) 02/2022 - 01/2009
9	Alcoholic Fatty Liver 10/2020 - 01/2013
8	Obesity 01/2020 - 01/2009
6	Weight Loss (Weight Reduction) 03/2022 - 01/2011
6	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2020 - 06/2010
5	Overweight 01/2022 - 06/2008
4	Hyperglycemia 01/2021 - 05/2012
3	Body Weight (Weight, Body) 03/2022 - 06/2008
3	Hypertriglyceridemia 09/2021 - 01/2020
3	Infections 01/2012 - 01/2008
2	Celiac Disease (Celiac Sprue) 02/2022 - 09/2018
2	Liver Neoplasms (Liver Cancer) 11/2020 - 01/2012
2	Genetic Predisposition to Disease (Genetic Predisposition) 01/2020 - 01/2019
2	Type 2 Diabetes Mellitus (MODY) 10/2019 - 01/2009
2	Birth Weight (Birth Weights) 01/2019 - 08/2017
2	Endotoxemia 01/2019 - 08/2015
2	Rhabdomyosarcoma 01/2016 - 07/2012
2	Hepatoblastoma 01/2016 - 05/2010
2	Glucose Intolerance 01/2016 - 06/2010
2	Atherosclerosis 02/2015 - 01/2009
2	Liver Failure 09/2013 - 06/2009

Drug/Important Bio-Agent (IBA)

21	Proteins (Proteins, Gene)FDA Link 02/2022 - 01/2005
13	Biomarkers (Surrogate Marker)IBA 02/2022 - 07/2010
11	Triglycerides (Triacylglycerol)IBA 03/2022 - 05/2009
9	LipidsIBA 01/2022 - 06/2010
9	Phospholipases (Phospholipase)IBA 01/2022 - 10/2010
9	AntioxidantsIBA 09/2021 - 06/2008
9	nasIBA 12/2019 - 06/2008
8	Focal Adhesion Protein-Tyrosine KinasesIBA 02/2022 - 03/2010
8	Alanine Transaminase (SGPT)IBA 01/2017 - 06/2008
6	MicroRNAs (MicroRNA)IBA 02/2022 - 02/2009
6	EnzymesIBA 01/2022 - 06/2008
6	CytokinesIBA 01/2021 - 01/2014
6	AdipokinesIBA 01/2020 - 05/2009
6	Glucose (Dextrose)FDA LinkGeneric 10/2019 - 05/2009
6	LipopolysaccharidesIBA 01/2019 - 07/2013
5	Pharmaceutical PreparationsIBA 02/2022 - 05/2010
5	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2022 - 05/2009
5	Insulin (Novolin)FDA Link 05/2021 - 01/2009
5	Docosahexaenoic AcidsIBA 01/2019 - 04/2011
4	Vitamin E FDA LinkGeneric 09/2021 - 02/2015
4	Transaminases (Aminotransferases)IBA 01/2021 - 06/2008
4	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 01/2020 - 01/2013
4	Vitamin D FDA LinkGeneric 01/2019 - 04/2014
3	Hyaluronic Acid (Hyaluronan)IBA 01/2022 - 10/2010
3	Messenger RNA (mRNA)IBA 10/2020 - 01/2018
3	Biological ProductsIBA 07/2020 - 05/2009
3	Bile Acids and Salts (Bile Acids)IBA 01/2020 - 07/2015
3	Nonesterified Fatty Acids (NEFA)IBA 01/2020 - 07/2012
3	FructoseIBA 01/2019 - 01/2011
3	Therapeutic UsesIBA 01/2018 - 01/2012
3	NF-kappa B (NF-kB)IBA 01/2015 - 09/2009
3	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2014 - 05/2011
3	Toll-Like Receptor 4IBA 07/2013 - 02/2010
2	CopperIBA 02/2022 - 04/2013
2	Sorafenib (BAY 43-9006)FDA Link 01/2022 - 11/2021
2	TAE226IBA 01/2022 - 11/2021
2	Keratin-18 (Keratin 18)IBA 01/2022 - 09/2013
2	HomocysteineIBA 01/2022 - 11/2014
2	Glutathione (Reduced Glutathione)IBA 01/2022 - 11/2014
2	procollagen Type III-N-terminal peptide (PIIP)IBA 01/2022 - 12/2019
2	ImmunosorbentsIBA 01/2022 - 11/2018
2	Collagen Type III (Type III Collagen)IBA 01/2022 - 12/2019
2	3,4-dihydroxyphenylethanol (hydroxytyrosol)IBA 09/2021 - 10/2019
2	oxidized low density lipoproteinIBA 04/2021 - 06/2010
2	Interleukin-6 (Interleukin 6)IBA 01/2021 - 06/2010
2	Peptides (Polypeptides)IBA 10/2020 - 01/2019
2	Antiviral Agents (Antivirals)IBA 07/2020 - 01/2008
2	Histones (Histone)IBA 01/2020 - 12/2013
2	HDL CholesterolIBA 01/2020 - 06/2010
2	CateninsIBA 10/2019 - 01/2016
2	Hemoglobins (Hemoglobin)IBA 10/2019 - 01/2017
2	HDL LipoproteinsIBA 01/2019 - 03/2016
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2019 - 02/2015
2	Insulin-Like Growth Factor I (IGF-1)IBA 01/2018 - 07/2014
2	Enhancer of Zeste Homolog 2 ProteinIBA 01/2017 - 12/2013
2	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2016 - 01/2016
2	AdiponectinIBA 08/2015 - 12/2012
2	Toll-Like Receptors (Toll-Like Receptor)IBA 11/2014 - 07/2013
2	CholesterolIBA 07/2014 - 05/2009
2	fibroblast growth factor 21IBA 02/2014 - 01/2013
2	IronIBA 04/2013 - 09/2011
2	CarbohydratesIBA 02/2012 - 01/2012
2	EndotoxinsIBA 03/2011 - 06/2010
1	Phytosterols (Plant Sterols)IBA 05/2022

Therapy/Procedure

18	Therapeutics 02/2022 - 01/2008
5	Gastrectomy 03/2022 - 01/2017
5	Drug Therapy (Chemotherapy) 01/2019 - 07/2012
4	Liver Transplantation 10/2020 - 05/2011
3	Gluten-Free Diet 02/2022 - 09/2018
2	Bariatric Surgery 03/2022 - 01/2017
2	Aftercare (After-Treatment) 01/2017 - 04/2011